Skip to main content

Table 1 Characteristics of study subjects according to treatment of latent tuberculosis infection

From: Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain

Variables Eligible for TLTBI Initiated
TLTBI
Completed TLTBI
  N (%) n (%) n (%)
Sex       
   Male 141 (77.9) 92 (75.4) 52 (74.3)
   Female 40 (22.1) 30 (24.6) 18 (25.7)
Age group (years)       
   ≤ 30 48 (26.5) 39 (32.0) 20 (28.6)
   31-35 53 (29.3) 33 (27.0) 15 (21.4)
   36-40 40 (22.1) 22 (18.0) 13 (18.6)
   ≥ 41 40 (22.1) 28 (23.0) 22 (31.4)
Country of origin       
   Spain 154 (85.1) 101 (82.8) 58 (82.9)
   Other 27 (14.9) 21 (17.2) 12 (17.1)
Educational level       
   None/incomplete primary education 24 (13.3) 14 (11.5) 6 (8.6)
   Primary education completed 80 (44.2) 54 (44.3) 33 (47.1)
   Secondary/university education completed 48 (26.5) 34 (27.9) 18 (25.7)
   Unknown 29 (16.0) 20 (16.3) 13 (18.6)
Employment status       
   Employed 73 (40.3) 49 (40.2) 33 (47.1)
   Unemployed 83 (45.9) 56 (45.9) 27 (38.6)
   Other 20 (11.0) 13 (10.6) 7 (10.0)
   Unknown 5 (2.8) 4 (3.3) 3 (4.3)
HIV transmission route       
   IDU 101 (55.8) 59 (48.4) 28 (40.0)
   MSM 22 (12.2) 17 (13.9) 7 (10.0)
   Heterosexual sex 53 (29.3) 44 (36.1) 34 (48.6)
   Other/unknown 5 ( 2.8) 2 (1.6) 1 (1.4)
Viral load (copies)       
   < 50 17 (9.4) 8 (6.6) 6 (8.6)
   50-9,999 57 (31.5) 43 (35.2) 29 (41.4)
   10,000-54,999 45 (24.9) 30 (24.6) 15 (21.4)
   ≥ 55,000 58 (32.0) 39 (32.0) 19 (27.1)
   Unknown 4 (2.2) 2 (1.6) 1 (1.4)
CD4 (cells/μL)       
   < 100 22 (12.2) 11 (9.0) 5 (7.1)
   100-199 24 (13.3) 16 (13.1) 10 (14.3)
   200-499 75 (41.4) 52 (42.6) 28 (40.0)
   ≥ 500 60 (33.1) 43 (35.2) 27 (38.6)
Hepatitis B carriers       
   Yes 14 (7.7) 9 (7.4) 3 (4.3)
   No 163 (90.1) 112 (91.8) 67 (95.7)
   Unknown 4 (2.2) 1 (0.8) 0 (0.0)
Hepatitis C virus antibodies       
   Yes 107 (59.1) 62 (50.8) 31 (44.3)
   No 69 (38.1) 57 (46.7) 38 (54.3)
   Unknown 5 (2.8) 3 (2.5) 1 (1.4)
TOTAL 181 (100.0) 122 (100.0) 70 (100.0)
  1. TLTBI: treatment of latent tuberculosis infection; IDU: Intravenous drug user; MSM: Men who have sex with men